Canopy Growth

History and Milestones

• Tweed founded in 2013, renamed Canopy Growth Corporation in 2015.
• First publicly traded cannabis producer in North America.
• Became Canada’s first cannabis unicorn with a $1 billion valuation.
• Legalization of marijuana for recreational use in Canada in 2018.
• Listed on the New York Stock Exchange in May 2018.

Partnerships and Investments

• Constellation Brands invested $5 billion in 2018, acquiring 38% ownership.
• Plans for cannabis-infused beverages and sleep aids.
• Market value rose to nearly $12 billion post the deal.
• Constellation Brands announced no further investments by end of 2019.
• Appointment of Constellation CFO David Klein as CEO.

International Operations and Expansion

• Operations in various countries like Spain, Germany, Denmark, Jamaica, etc.
• Acquisitions of Annabis Medical in Czech Republic and Daddy Cann Lesotho in Africa.
• Expansion into Europe and the US.
• Acquisition of Vert Medical, MedCann, and Groupe H.E.M.P.CA Inc.
• Prepared for increased demand in recreational market.

Financial Challenges and Strategic Decisions

• Restructuring charges for returns and pricing allowances.
• Stock price declines and market value losses.
• Appointment of David Klein as CEO leading to share price surge.
• Closure of sites in Canada as part of strategic restructuring.
• Engaged in international expansion and acquisitions.

Regulatory Environment and Industry Performance

• Monitoring federal legislation and adapting to regulatory changes.
• Obtained licenses for medical cannabis production.
• Revenue growth and serving more patients.
• Leading player in the global cannabis market.
• Diversification into new product categories like edibles and addressing industry challenges.

Canopy Growth Data Sources